Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 376 of 1,261
  1. US 10874709

    Conjugate of salicylic acid and peptide

    CAREGEN CO., LTD. · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  2. US 10874649

    2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors

    Valo Early Discovery, Inc. · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  3. US 10874673

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  4. US 10874633

    Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity

    Auransa Inc. · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  5. US 10874609

    ß-cyclodextrin-based star-shaped polymer, a preparation method therefor and an integrated unimolecular micelle system for diagnosis and treatment thereof

    South China University of Technology · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  6. US 10874676

    Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome

    ESSENTIALIS, INC. · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  7. US 10874748

    Intervention for tendinopathy

    Montefiore Medical Center · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  8. US 10875907

    Filovirus antibody

    The Government of the United States, as represented by the Secretary of the Army · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  9. US 10875911

    High affinity human antibodies to human angiopoietin-2

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  10. US 10875913

    Methods of treatment using activatable anti-EGFR antibodies

    CytomX Therapeutics, Inc. · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  11. US 10875920

    Antibodies and molecules that immunospecifically bind to BTN1A1 and the therapeutic uses thereof

    The Board of Regents of the University of Texas System · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  12. LT 3254695

    COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER

    ASTELLAS PHARMA INC [JP] · Granted Dec 28, 2020 · Expires Dec 23, 2040

    granted
  13. EP 3752616

    ZUSAMMENSETZUNGEN UND VERFAHREN ZUR GENEDITIERUNG DURCH TARGETING VON FIBRINOGEN-ALPHA

    CRISPR THERAPEUTICS AG [CH] · Granted Dec 23, 2020 · Expires Dec 18, 2040

    granted
  14. US 10869901

    Hydrolyzed chicken sternal cartilage extract, method for producing the same and use thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted
  15. US 10870855

    Use of MIR101 or MIR128 in the treatment of seizure disorders

    OVID THERAPEUTICS INC. · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted
  16. US 10870672

    β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

    Atea Pharmaceuticals, Inc. · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted
  17. US 10869920

    Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted
  18. US 10869851

    Targeting NUR77 for mitigating perinatal neuroinflammation

    United States Government as represented by the Secretary of the Army · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted
  19. US 10870854

    Inhibitory RNA-based therapeutics targeting ANLN for cancer treatment

    The Board of Regents of the University of Texas System · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted
  20. US 10870837

    Fusion proteins comprising enzyme replacement therapy enzymes

    DENALI THERAPEUTICS INC. · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted
  21. US 10870687

    Anti-human papillomavirus 16 E7 T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted
  22. US 10870673

    β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

    Atea Pharmaceuticals, Inc. · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted
  23. US 10870842

    Stabilized alpha-galactosidase and uses thereof

    Protalix Ltd. · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted
  24. US 10870679

    Modulation of structured polypeptide specificity

    BicycleRD Limited · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.